High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$40K
$40,304
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALLO
S
Allogene Therapeutics, Inc.
Douglas Earl Martin
• Officer • SVP, General Counsel
Sell to Cover
2026-02-02
$40,304
|
||||||
| ALLO |
Allogene Therapeutics, Inc.
|
Officer • SVP, General Counsel
Sell to Cover
|
2026-02-02 | $40,304 | S | Form 4 |